Jensen G, Zachrisson B F, Volkmann R, Aurell M
Avdelningen för njurmedicin, Sahlgrenska Universitetssjukhuset/Sahlgrenska, Göteborg.
Lakartidningen. 1998 Sep 16;95(38):4068, 4071-4.
Although renovascular hypertension is associated with substantial cardiovascular morbidity, ultimately it is a curable disease. Early identification and appropriate treatment of renovascular hypertension may save years of antihypertensive therapy, reduce the morbidity associated with long-standing hypertension, and help to minimise the risk of renal failure. However, the main problem is to identify patients with renovascular disease suitable for treatment. This requires alertness in the clinician, and renographic screening of renal function or duplex-ultrasound scanning of renovascular circulation to augment the yield of angiographic procedures. The predominant treatment of renovascular disease today is percutaneous transluminal angioplasty, which can be used as a repeat procedure or in combination with endoluminal stenting of the stenotic renal artery.
尽管肾血管性高血压与严重的心血管疾病发病率相关，但它最终是一种可治愈的疾病。早期识别和适当治疗肾血管性高血压可以节省数年的抗高血压治疗时间，降低与长期高血压相关的发病率，并有助于将肾衰竭风险降至最低。然而，主要问题是识别适合治疗的肾血管疾病患者。这需要临床医生保持警觉，并对肾功能进行肾造影筛查或对肾血管循环进行双功超声扫描，以提高血管造影检查的阳性率。目前肾血管疾病的主要治疗方法是经皮腔内血管成形术，该方法可作为重复治疗手段，或与狭窄肾动脉的腔内支架置入术联合使用。
